Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

ALG13 Activators

ALG13 UDP-N-acetylglucosaminyltransferase subunit activators encompass a range of small molecules that enhance its enzymatic activity, particularly in the context of protein glycosylation. These activators include compounds that directly supply substrates for the glycosylation process, such as nucleotide sugars that ALG13 utilizes to transfer N-acetylglucosamine to nascent glycoproteins. The process is further optimized by the presence of essential metal cofactors, which are integral for the catalytic activity of this enzyme, thus by increasing the availability of these cofactors, the efficiency and functional activity of ALG13 can be significantly improved. Additional compounds exert their activating influence by modulating secondary cellular processes which, in turn, enhance the glycosylation capacity of the cell, thereby indirectly promoting the function of ALG13. For instance, molecules that disrupt normal Golgi apparatus function may induce compensatory mechanisms that result in upregulated glycosyltransferase activities, including those mediated by ALG13.

Moreover, certain activators work by augmenting the pool of high-energy molecules and cofactors that are necessary for the multitude of enzymatic reactions taking place within the glycosylation pathway. These include, but are not limited to, donors of high-energy phosphate bonds and reducing equivalents, which are essential for the synthesis of glycoconjugates. The increased availability of these biochemical constituents can result in a more robust glycosylation environment, conducive to the activity of glycosyltransferases such as ALG13. Furthermore, some activators may lead to an upregulated ALG13 activity by triggering cellular stress responses to perturbations in the glycosylation machinery, thereby eliciting a cellular adaptation aimed at restoring homeostasis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Activates adenylyl cyclase, increasing cAMP levels. Elevated cAMP enhances protein glycosylation, supporting ALG13 function.

Uridine-5′-diphosphoglucose, disodium salt

117756-22-6sc-296687
sc-296687A
sc-296687B
sc-296687C
sc-296687D
sc-296687E
100 mg
1 g
10 g
50 g
100 g
1 kg
$99.00
$458.00
$2611.00
$13015.00
$16657.00
$41106.00
1
(1)

Serves as a glucosyl donor for glycosyltransferases, directly fueling the glycosylation process where ALG13 is involved.

Manganese(II) chloride beads

7773-01-5sc-252989
sc-252989A
100 g
500 g
$19.00
$31.00
(0)

Required as a cofactor for glycosyltransferases, thus optimizing the enzymatic function of ALG13.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts Golgi structure, inducing a compensatory response that can enhance glycosyltransferase activities including ALG13.

β-Nicotinamide adenine dinucleotide phosphate

53-59-8sc-215560
sc-215560A
100 mg
250 mg
$182.00
$319.00
(1)

Participates in biosynthetic reactions, providing reducing power that can indirectly support ALG13 enzymatic activity.

D-Glucosamine

3416-24-8sc-278917A
sc-278917
1 g
10 g
$201.00
$779.00
(0)

Provides substrate for the hexosamine biosynthetic pathway, indirectly enhancing glycosyltransferase activity of ALG13.

Magnesium chloride

7786-30-3sc-255260C
sc-255260B
sc-255260
sc-255260A
10 g
25 g
100 g
500 g
$28.00
$35.00
$48.00
$125.00
2
(1)

Acts as an essential cofactor for many enzymes including glycosyltransferases, potentially enhancing ALG13 activity.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Inhibits N-linked glycosylation, leading to compensatory cellular responses that may upregulate ALG13 activity.